Investigator
Robert Harper
ANALYTICAL DIAGNOSTIC SOLUTIONS, INC. · funded by NCATS, NICHD
- Companies
- 2
- Grants
- 2
- Non-dilutive funding
- $1.2M
- First award
- Sep 20, 2023
Resolved onto their grants.
Federal awards on file.
Summed across those awards.
Latest Jul 1, 2025.
Companies from this work
Pre-ticker companies the crosswalk resolved onto a grant filed under this investigator. Momentum shows for the therapeutic areas your seat covers; open a dossier for the full crosswalk.
- ANALYTICAL DIAGNOSTIC SOLUTIONS, INC.Momentum in another area
Rare diseaseGrant-only
- ANALYTICAL DIAGNOSTIC SOLUTIONS, INC.25momentum
OncologyGrant-only
Grant record
Federal awards filed under this investigator name, newest first. Each links to the public record where the awarding agency publishes one.
- R43
A point-of-care device for the determination of homocysteine (Hcy), the Hcy Now
$305kJul 1, 2025NCATSANALYTICAL DIAGNOSTIC SOLUTIONS, INC.NIH RePORTER · 11068896 (opens the source filing in a new tab)
- R44
A point of care-device for the determination of creatinine phosphokinase (CPK), theCPK Now
$906kSep 20, 2023NICHDANALYTICAL DIAGNOSTIC SOLUTIONS, INC.NIH RePORTER · 11253099 (opens the source filing in a new tab)
This page aggregates public U.S. federal grant records filed under one investigator name and the companies Biodatica has resolved onto them. Names are shown as the awarding agency filed them; grant awards are non-dilutive federal funding, not equity or valuation. Distinct people who file under the same name would appear together here. It is informational only and not investment advice. Methodology · Data sources